| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 04/08/2004 | US20040068115 Charge transport compositions and electronic devices made with such compositions |
| 04/08/2004 | US20040068109 Activated blood coagulation factor X inhibitor and also to such a pharmaceutical agent and particularly has an excellent activity by oral administration |
| 04/08/2004 | US20040067999 Carbazole derivatives and their use as neuropeptide y5 receptor ligands |
| 04/08/2004 | US20040067996 Antiarthritic agents; osteoporosis; antitumor agents; antiulcer agents; antiinflammatory agents |
| 04/08/2004 | US20040067985 Anticancer agents |
| 04/08/2004 | US20040067983 Corticotropin releasing factor moderator; analgesics; drug abruse, drug dependency; schizophrenia |
| 04/08/2004 | US20040067976 Compounds useful for treating Hepatitis C virus |
| 04/08/2004 | US20040067968 Antitumor, anticancer agents |
| 04/08/2004 | US20040067961 Organ grafting; antiarthritic agents; inflammatory bowel disease |
| 04/08/2004 | US20040067944 Antiarrhythmia agents |
| 04/08/2004 | US20040067940 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease |
| 04/08/2004 | US20040067938 Quaternary amines and related inhibitors of factor xa |
| 04/08/2004 | US20040067935 N-substituted heterocyclic amines as modulators of chemokine receptor activity |
| 04/08/2004 | US20040067914 R-NSAID esters and their use |
| 04/08/2004 | US20040067872 Novel mono- and di-fluorinated benzothiepine compouds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake |
| 04/08/2004 | US20040067531 Methods of modulating protein tyrosine kinase function with substituted indolinone compounds |
| 04/08/2004 | US20040067387 Organic compounds for electroluminescence and organic electroluminescent devices using the same |
| 04/08/2004 | US20040066135 Electronic devices made with electron transport and/or anti-quenching layers |
| 04/08/2004 | US20040065866 Low viscosity; solubility at low temperature; low voltage display device |
| 04/08/2004 | CA2500231A1 Pyridine derivatives as cb2 receptor modulators |
| 04/07/2004 | EP1405848A1 Tetrahydroquinoline derivative compound and drug containing the compound as active ingredient |
| 04/07/2004 | EP1404669A2 Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases |
| 04/07/2004 | EP1404668A1 Variolin derivatives and their use as antitumor agents |
| 04/07/2004 | EP1404662A2 Process for preparing isocoumarins |
| 04/07/2004 | EP1404653A1 Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion |
| 04/07/2004 | EP1404335A1 Amino nicotinate derivatives as glucokinase (glk) modulators |
| 04/07/2004 | EP1404321A1 1-alkyl-2-aryl-benzimidazole derivatives, their use for producing medicaments and pharmaceutical preparations containing said derivatives |
| 04/07/2004 | EP0973512B1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 04/07/2004 | EP0836511B1 Device for transdermal electrotransport delivery of fentanyl and sufentanil |
| 04/07/2004 | CN1487933A Pyrazole compounds useful as protein kinase inhibitors |
| 04/07/2004 | CN1487924A Farnesyl transferase inhibitors |
| 04/07/2004 | CN1486985A Synthesis of anticancer medicine Raltiprexed |
| 04/07/2004 | CN1144799C N-(iminomethyl) amine derivatives, their preparation, their use as medicines and medical compositions containing the same |
| 04/07/2004 | CN1144791C Triazole compounds and its application as dopamine-D3-ligands |
| 04/07/2004 | CN1144786C Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 04/07/2004 | CN1144785C Hydroxamic acid and its preparation, and pharmaceutical composition |
| 04/06/2004 | US6716995 Design and synthesis of advanced NLO materials for electro-optic applications |
| 04/06/2004 | US6716991 Process for preparing a substituted pyrazolyl benzenesulfonamide for the treatment of inflammation |
| 04/06/2004 | US6716871 Cyclic AMP-specific phosphodie sterase inhibitors |
| 04/06/2004 | US6716866 Aryl-benzimidazole compounds having antiinfective activity |
| 04/06/2004 | US6716855 Antithrombotic amides |
| 04/06/2004 | US6716850 Non-nucleoside reverse transcriptase inhibitors |
| 04/06/2004 | US6716847 Antiallergens, antiinflammatory |
| 04/06/2004 | US6716839 Inhibitor of factor xa |
| 04/06/2004 | US6716837 Heterocyclic compounds for the treatment of migraine |
| 04/06/2004 | US6716834 Thiochromane derivatives and their use as thrombin inhibitors |
| 04/06/2004 | US6716257 Oxidation dyes, which are used for treatment of human hair |
| 04/06/2004 | CA2124306C Quinazolinone derivatives |
| 04/06/2004 | CA2104515C Composition for accelerating healing of wound |
| 04/01/2004 | WO2004027046A2 Methods of producing 4-amino-3-mercapto-triazoles |
| 04/01/2004 | WO2004026881A1 Macrocyclic pyrimidines, the production thereof and the use of the same as medicaments |
| 04/01/2004 | WO2004026864A1 Heterocyclic substituted piperazines for the treatment of schizophrenia |
| 04/01/2004 | WO2004026858A1 Substituted heterocyclylpyrimidines |
| 04/01/2004 | WO2004026844A1 Methods and compositions of novel triazine compounds |
| 04/01/2004 | WO2004026843A1 Benzodiazepine derivatives and pharmaceutical compositions containing them |
| 04/01/2004 | WO2004026831A1 2,4-substituted indoles and their use as 5-ht6 modulators |
| 04/01/2004 | WO2004026305A1 Diaryl ethers as opioid receptor antagonist |
| 04/01/2004 | WO2004026264A2 Novel aromatic compounds possessing antifungal or antibacterial activity |
| 04/01/2004 | WO2004026230A2 Method of preparing amino acid taxane derivatives and polymer conjugates containing the same |
| 04/01/2004 | WO2004006352A3 Electronic devices made with electron transport and/or anti-quenching layers |
| 04/01/2004 | WO2003099284B1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 04/01/2004 | WO2003059874A3 Aromatic thioether liver x-receptor modulators |
| 04/01/2004 | WO2003028652A3 Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis |
| 04/01/2004 | WO2003008410A8 Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression |
| 04/01/2004 | WO2002098852A8 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins |
| 04/01/2004 | WO2002085897A9 Heterocyclic compounds for aging-related and diabetic vascular complications |
| 04/01/2004 | US20040063985 Bis(alkylthio)carbenium salts |
| 04/01/2004 | US20040063955 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines |
| 04/01/2004 | US20040063940 3,3-Biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 04/01/2004 | US20040063935 Aliphatic nitrogenous five-membered ring compounds |
| 04/01/2004 | US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes |
| 04/01/2004 | US20040063765 Modulation of pathogenicity |
| 04/01/2004 | US20040063757 Urotensin-ll receptor antagonists |
| 04/01/2004 | US20040063756 Administering a therapeutically effective amount of 2-Aminoquinolines for the prevention or treatment of eating disorders, weight gain and obesity |
| 04/01/2004 | US20040063755 Aromatic compounds containing hydroxyalkylaminoalkylphenylaminophenyl group; useful for treating pre-term labor, neurological disorders and cardiac disorders |
| 04/01/2004 | US20040063737 CDK-inhibitory 2-heteroaryl-pyrimidines, their production and use as pharmaceutical agents |
| 04/01/2004 | US20040063735 Calcitonin gene related peptide receptor antagonists |
| 04/01/2004 | US20040063709 Acute and chronic inflammatory disorders; cancer |
| 04/01/2004 | US20040063701 Potent and specific serotonin 2 receptor inhibition with low adverse side effects; such as 1-formyl-N-(2-(4-(5H-dibenzo-(a,d)cyclohepten-5-ylidene)-1 -piperidinyl))ethylisonipecot-amide |
| 04/01/2004 | US20040063693 5-HT2A receptor related disorders; such as 1-(2-(2-fluoro-4-nitrophenoxy)ethyl)-3-(1piperazinyl)-2(1H)-pyrazinone |
| 04/01/2004 | US20040063691 Preparation and use of imidazole derivatives for treatment of obesity |
| 04/01/2004 | US20040063669 Alpha-phenyl-beta-ketosulfone |
| 04/01/2004 | US20040063645 Such as ((2-(3-guanidino-2-hydroxy-propylcarbamoyl)-1H-indol-5-yl)-amide) |
| 04/01/2004 | US20040063643 Bombesin antagonists |
| 04/01/2004 | DE10243939A1 Pyrroline Pyrrolines |
| 04/01/2004 | CA2499964A1 Methods and compositions of novel triazine compounds |
| 04/01/2004 | CA2499326A1 Heterocyclic substituted piperazines for the treatment of schizophrenia |
| 04/01/2004 | CA2498946A1 2,4-substituted indoles and their use as 5-ht6 modulators |
| 04/01/2004 | CA2496306A1 Substituted heterocyclylpyrimidines |
| 04/01/2004 | CA2492319A1 Macrocyclic pyrimidines, the production thereof and the use of the same as medicaments |
| 03/31/2004 | EP1403269A1 Remedial agent for viral infectious disease |
| 03/31/2004 | EP1403255A1 Rho KINASE INHIBITORS |
| 03/31/2004 | EP1403250A1 Bis(5-aryl-2-pyridyl) derivative |
| 03/31/2004 | EP1401833A2 Chemical derivatives and the use thereof as an anti-elomerase agent |
| 03/31/2004 | EP1401830A2 Quinazolinediones as antibacterial agents |
| 03/31/2004 | EP1401827A2 Herbicidal substituted pyridines, method for producing the same and their use as herbicidal agents and plant growth regulators |
| 03/31/2004 | EP1401826A1 Pyrazole derivatives as hiv reverse transcriptase inhibitors |
| 03/31/2004 | EP1401825A2 Thiophene derivatives as antiviral agents for flavivirus infection |
| 03/31/2004 | EP1401824A2 Aromatic hydroxamic acid derivatives useful as hdac inhibitors |
| 03/31/2004 | EP1401821A1 Novel phenylalkyl diamine and amide analogs |